|
Atomistry » Fluorine » PDB 4c6l-4cqj » 4cmo | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4c6l-4cqj » 4cmo » |
Fluorine in PDB 4cmo: Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-MethylbenzamideEnzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide
All present enzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide:
2.7.10.1; Protein crystallography data
The structure of Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide, PDB code: 4cmo
was solved by
M.A.Mctigue,
Y.L.Deng,
W.Liu,
A.Brooun,
A.E.Stewart,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide
(pdb code 4cmo). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide, PDB code: 4cmo: Fluorine binding site 1 out of 1 in 4cmoGo back to Fluorine Binding Sites List in 4cmo
Fluorine binding site 1 out
of 1 in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with the Inhibitor 2-((1R)-1-((3-Amino-6-(2- Methoxypyridin- -Yl)Pyrazin-2-Yl)Oxy)Ethyl)-4-Fluoro-N-Methylbenzamide
Mono view Stereo pair view
Reference:
T.W.Johnson,
P.F.Richardson,
S.Bailey,
A.Brooun,
B.J.Burke,
M.R.Collins,
J.J.Cui,
J.G.Deal,
Y.L.Deng,
D.M.Dinh,
L.D.Engstrom,
M.He,
J.E.Hoffman,
R.L.Hoffman,
Q.Huang,
J.Kath,
R.S.Kania,
H.Lam,
J.L.Lam,
P.T.Le,
L.Lingardo,
W.Liu,
M.A.Mctigue,
C.L.Palmer,
N.W.Sach,
T.Smeal,
G.L.Smith,
A.E.Stewart,
S.L.Timofeevski,
H.Zhu,
J.Zhu,
H.Y.Zou,
M.P.Edwards.
Discovery of (10R)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15- Oxo-10,15,16,17-Tetrahydro-2H-8,4-(Metheno)Pyrazolo[4,3- H][2,5,11]Benzoxadiazacyclotetradecine-3-Carbonitrile (Pf- 06463922), A Macrocyclic Inhibitor of Alk/ROS1 with Pre- Clinical Brain Exposure and Broad Spectrum Potency Against Alk-Resistant Mutations. J.Med.Chem. V. 57 4720 2014.
Page generated: Thu Aug 1 00:45:24 2024
ISSN: ISSN 0022-2623 PubMed: 24819116 DOI: 10.1021/JM500261Q |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |